ANO Proteins: Potential Drug Targets (P48979)

Target Name: Anoctamin

NCBI ID: P48979

Anoctamin

Other Name(s): ANO

ANO Proteins: Potential Drug Targets

Anoctamin, also known as ANO or subtype ANO, is a protein that is expressed in various tissues throughout the body. It is a member of the protein family that provides gas exchange services, namely the HO gene family. Plays important biological functions, such as assisting in the exchange of oxygen and carbon dioxide in lung tissue.

In recent years, researchers have conducted more and more in-depth studies on ANO proteins. Research shows that ANO proteins play an important role in a variety of diseases, such as cancer, neurodegenerative diseases, inflammation and immune disorders. These findings make the ANO protein a potential drug target (or biomarker).

First, the role of ANO proteins in cancer is well established. Studies have shown that the expression level of ANO protein is closely related to the prognosis and treatment response of various cancers. For example, the expression level of ANO protein is positively correlated with the survival rate, symptom remission, and overall survival rate of lung cancer patients. In addition, the expression level of ANO protein is closely related to the prognosis and treatment response of cancers such as ovarian cancer and breast cancer. Therefore, ANO protein is considered a potential cancer therapeutic target.

Secondly, the role of ANO proteins in neurodegenerative diseases has also received attention. For example, research shows that the ANO protein plays an important role in the brain and may be closely related to the occurrence and development of neurodegenerative diseases. In addition, ANO protein is closely associated with survival, symptom remission, and overall survival in patients with neurodegenerative diseases. Therefore, ANO protein is considered a potential therapeutic target for neurodegenerative diseases.

Additionally, the role of ANO proteins in inflammation and immune dysregulation has been studied. Research shows that ANO protein plays an important role in inflammation and immune dysregulation and may be closely related to the occurrence and development of a variety of inflammatory and immune dysregulation diseases. Therefore, ANO protein is considered a potential therapeutic target for inflammation and immune disorders.

In addition to their role in disease, ANO proteins have other biological functions. For example, the ANO protein is a protein that binds oxygen and carbon dioxide and plays an important role in the gas exchange process. In addition, ANO proteins are also involved in biological processes such as cell signaling, cell adhesion, and cell migration.

In summary, the ANO protein is a potential drug target (or biomarker). It is closely related to the occurrence and development of many diseases, including cancer, neurodegenerative diseases, inflammation and immune disorders. Therefore, the ANO protein is a biological molecule worthy of further study.

Protein Name: Anoctamin (nonspecified Subtype)

The "Anoctamin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Anoctamin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets